The global cardiovascular drugs market size is expected to reach approximately USD 231.7 billion by 2030, from a value of USD 155.6 billion in 2021 and growing at a CAGR of 4.52% between 2022 and 2030. According to Precedence Research, the global cardiovascular drug market size stood at $162.64 billion in 2022. Rapid modernization has increased the consumption of fast foods and unhealthy lifestyles, which has increased the number of cases with cardiovascular disorders. Lack of physical activity in people due to a busy schedule increases the rate of cardiovascular disorders. This leads to an increase in demand and supply of essential cardiovascular drugs which prove to be life-saving for patients. Many cardiovascular disorders require palliative treatment which is helping to boost the market. Cardiovascular medications cannot be discontinued easily by a patient as it requires good judgment of the patient's heart health, which can prove fatal in the long run. Therefore, cardiovascular drugs are finding an important place in the healthcare industry market.